Does the SHBG rs6259 variant raise circulating SHBG levels?

Sex hormone–binding globulin (SHBG) is a transport glycoprotein that regulates the bioavailability of sex steroids, such as testosterone and estradiol. The SHBG gene contains several polymorphisms that influence protein synthesis and clearance, with the rs6259 variant being one of the most well-studied genetic determinants of circulating levels.

Clinical evidence and effect size

Large-scale genomic studies and targeted clinical evaluations consistently demonstrate that the rs6259 variant (specifically the minor A-allele) is associated with significantly higher levels of circulating SHBG.

• Population studies: Research in healthy male populations and diverse cohorts (including Japanese and Caucasian groups) shows that carriers of the A-allele (genotypes AG or AA) exhibit higher SHBG concentrations compared to those with the wild-type GG genotype.
• Magnitude of effect: In clinical settings, individuals heterozygous for the variant (AG) typically show SHBG concentrations approximately 10.8% to 23.1% higher than those with the GG genotype. Meta-analyses have confirmed this directional effect, with the minor (Asn) allele explaining a substantial portion of the heritable variance in SHBG levels.

Mechanistic explanations

The rs6259 polymorphism involves a single nucleotide substitution (G>A) that results in an amino acid change from aspartic acid to asparagine at position 327 (Asp327Asn).

• Glycosylation: This amino acid substitution creates a new consensus sequence for N-linked glycosylation in the third domain of the SHBG protein.
• Protein stability: The additional carbohydrate chain at position 327 significantly enhances the post-translational processing of the protein. This modification reduces the clearance rate of the protein from the blood, resulting in a prolonged half-life and increased protein stability.
• Secretion: Studies in human hepatoma cell lines have also indicated that this modification may slightly increase the rate of protein secretion into the extracellular environment.

Bottom line

The association between the SHBG rs6259 variant and higher circulating SHBG levels is well-supported by scientific evidence. For a 48-year-old male, carrying this variant would likely result in higher SHBG concentrations, which may subsequently influence the levels of free (bioavailable) testosterone, even if total testosterone levels remain within normal ranges.